Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment.
about
Differential Effect of the Dopamine D3 Agonist (±)-7-Hydroxy-2-(N,N-di-n-propylamino) Tetralin (7-OH-DPAT) on Motor Activity between Adult Wistar and Sprague-Dawley Rats after a Neonatal Ventral Hippocampus Lesion.Cholinergic systems are essential for late-stage maturation and refinement of motor cortical circuits.Regulation of cortical acetylcholine release: insights from in vivo microdialysis studiesA systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of ratsTransient inactivation of the neonatal ventral hippocampus permanently disrupts the mesolimbic regulation of prefrontal cholinergic transmission: implications for schizophreniaNicotine effects in adolescence and adulthood on cognition and α₄β₂-nicotinic receptors in the neonatal ventral hippocampal lesion rat model of schizophrenia.Acetylcholine Acts through Nicotinic Receptors to Enhance the Firing Rate of a Subset of Hypocretin Neurons in the Mouse Hypothalamus through Distinct Presynaptic and Postsynaptic Mechanisms(.)Transient inactivation of the neonatal ventral hippocampus impairs attentional set-shifting behavior: reversal with an α7 nicotinic agonist.Cholinergic suppression of visual responses in primate V1 is mediated by GABAergic inhibition.Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamineCholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatmentsEnhanced control of attention by stimulating mesolimbic-corticopetal cholinergic circuitry.Acute and chronic effects of clozapine on cholinergic transmission in cultured mouse superior cervical ganglion neurons.
P2860
Q30412496-2B64BB42-0FD4-49C3-97E3-4B9990675D02Q30624044-885580DC-710C-4367-B3CF-06BBDB9FC95DQ34077418-9EC7BFC3-3508-456C-9154-01D80D605254Q35213516-378F7F21-AAC6-45E2-B3B3-F2D877235BABQ35356707-2467FE84-766B-45E0-95BA-A61ABA390469Q35547417-A649305C-F451-4A56-9B47-65171E1A4F46Q36001330-21009CF5-0655-49A7-9FDD-25D5E35C9732Q36234254-525080DB-92A2-4A8A-B325-55F6A6FA0BBAQ36532534-8F1D22ED-BDD4-4AAC-9051-1792FCE97898Q36755954-F57EDBB1-9147-41AB-AEE3-F645676EBE48Q37576675-EAD43560-83FB-47AE-9A4D-97149B2AEF49Q42815132-96035173-C737-4E5A-945D-FB6A659F8241Q51810889-5397F597-59C0-4F36-AD47-8A2070337D9B
P2860
Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Disruption of mesolimbic regul ...... y chronic clozapine treatment.
@en
Disruption of mesolimbic regul ...... y chronic clozapine treatment.
@nl
type
label
Disruption of mesolimbic regul ...... y chronic clozapine treatment.
@en
Disruption of mesolimbic regul ...... y chronic clozapine treatment.
@nl
prefLabel
Disruption of mesolimbic regul ...... y chronic clozapine treatment.
@en
Disruption of mesolimbic regul ...... y chronic clozapine treatment.
@nl
P2093
P2860
P356
P1476
Disruption of mesolimbic regul ...... y chronic clozapine treatment.
@en
P2093
John P Bruno
Julie M Brooks
Kathleen S Alexander
Martin Sarter
P2860
P2888
P304
P356
10.1038/NPP.2009.105
P407
P577
2009-08-19T00:00:00Z
P5875
P6179
1018279865